Catalent Investor Presentation January 2024

Catalent, a contract development and manufacturing organization (CDMO), presents financial performance and forward-looking guidance. The presentation discusses operations across its pharmaceutical and advanced modalities segments, risk factors including COVID-19 demand decline, and strategic initiatives for shareholders.